Your browser doesn't support javascript.
loading
High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study.
Créange, Alain; Hutin, Emilie; Sedel, Frédéric; Le Vigouroux, Ludivine; Lefaucheur, Jean-Pascal.
Affiliation
  • Créange A; AP-HP, Hôpital Henri Mondor, Service de Neurologie, 94010, Créteil, France. alain.creange@aphp.fr.
  • Hutin E; AP-HP, Hôpital Henri Mondor, CRC SEP Grand Paris Est, 94010, Créteil, France. alain.creange@aphp.fr.
  • Sedel F; Université Paris Est Créteil, EA4391, ENT, F-94010, Créteil, France. alain.creange@aphp.fr.
  • Le Vigouroux L; Laboratoire Analyse Et Restauration du Mouvement, Service de Rééducation Neurolocomotrice, AP-HP, Hôpital Henri Mondor, 94010, Créteil, France.
  • Lefaucheur JP; Université Paris Est Créteil, EA 7377, BIOTN, F-94010, Créteil, France.
BMC Neurol ; 23(1): 389, 2023 Oct 30.
Article in En | MEDLINE | ID: mdl-37899433
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Charcot-Marie-Tooth Disease / Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Language: En Journal: BMC Neurol Year: 2023 Type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Charcot-Marie-Tooth Disease / Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Language: En Journal: BMC Neurol Year: 2023 Type: Article Affiliation country: France